“…One is the increase in cellular motility driven by podoplanin interacting with the ERM proteins-Rho GTPases axis; the second is what we call "effective cohesiveness" in the cells. Effective cohesiveness designates a sensor mechanism or metabolite that would integrate the overall adhesive properties of a cell, and could be regulated by transcriptional and epigenetic mechanisms, protein stability, presence in the plasma membrane and context-specific mechanisms (like, for instance, the properties of the extracellular matrix) (Adhikary et al, 2014;Boulter et al, 2012;Engl et al, 2014;Friedl et al, 2014;Gueron et al, 2014;Marjoram et al, 2014;McGrail et al, 2014;Murali and Rajalingam, 2014;Orgaz et al, 2014;Sadok and Marshall, 2014;Thiery et al, 2012;50 Zegers and Friedl, 2014). If podoplanin is expressed in a cellular context with low effective cohesiveness, it will promote mesenchymal motility that will end up in EMT.…”